{"id":3976,"date":"2023-02-27T15:19:01","date_gmt":"2023-02-27T14:19:01","guid":{"rendered":"https:\/\/www.access2meds.eu\/pagina-de-inicio\/"},"modified":"2025-06-24T10:24:56","modified_gmt":"2025-06-24T08:24:56","slug":"pagina-de-inicio","status":"publish","type":"page","link":"https:\/\/www.access2meds.eu\/es\/","title":{"rendered":"P\u00e1gina de inicio"},"content":{"rendered":"<p>[et_pb_section fb_built=\u00bb1&#8243; admin_label=\u00bbHeader\u00bb _builder_version=\u00bb4.20.2&#8243; _module_preset=\u00bbdefault\u00bb background_image=\u00bbhttps:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/iStock-1217229190_Nastasic.jpg\u00bb background_position=\u00bbtop_center\u00bb height=\u00bb100vh\u00bb max_height=\u00bb660px\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_row _builder_version=\u00bb4.20.0&#8243; _module_preset=\u00bbdefault\u00bb custom_padding=\u00bb7px|30px||30px|false|true\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4&#8243; _builder_version=\u00bb4.20.0&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.20.2&#8243; _module_preset=\u00bbdefault\u00bb header_font=\u00bb|700|||||||\u00bb header_line_height=\u00bb1.1em\u00bb custom_margin=\u00bb11px||||false|false\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<h1><span style=\"color: #e95f6c;\">MEJORANDO EL ACCESO A<\/span> <br \/>TECNOLOG\u00cdAS SANITARIAS INNOVADORAS<\/h1>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=\u00bb1&#8243; admin_label=\u00bbfirst text blue pill\u00bb _builder_version=\u00bb4.20.0&#8243; _module_preset=\u00bbdefault\u00bb background_enable_color=\u00bboff\u00bb custom_padding=\u00bb0px||0px||false|false\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_row custom_padding_last_edited=\u00bbon|phone\u00bb module_class=\u00bbstarttoppill\u00bb _builder_version=\u00bb4.20.2&#8243; _module_preset=\u00bbdefault\u00bb background_color=\u00bb#3b3e84&#8243; vertical_offset=\u00bb-90px\u00bb max_width=\u00bb1500px\u00bb module_alignment=\u00bbright\u00bb custom_margin=\u00bb||||false|false\u00bb custom_padding=\u00bb60px||50px|93px|false|false\u00bb custom_padding_tablet=\u00bb60px||50px|93px|false|false\u00bb custom_padding_phone=\u00bb|10px||65px|false|false\u00bb custom_css_main_element=\u00bbwidth:calc(100% &#8211; 125px)!important;\u00bb border_radii=\u00bboff|99999px|||99999px\u00bb global_colors_info=\u00bb{}\u00bb custom_css_main_element_last_edited=\u00bbon|phone\u00bb custom_css_main_element_phone=\u00bbwidth:calc(100%)!important;\u00bb custom_css_main_element_tablet=\u00bbwidth:calc(100% &#8211; 125px)!important;\u00bb][et_pb_column type=\u00bb4_4&#8243; _builder_version=\u00bb4.20.0&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.20.2&#8243; _module_preset=\u00bbdefault\u00bb text_font=\u00bb||||||||\u00bb text_text_color=\u00bb#FFFFFF\u00bb text_font_size=\u00bb24px\u00bb text_line_height=\u00bb1.33em\u00bb width=\u00bb100%\u00bb max_width=\u00bb825px\u00bb custom_margin_tablet=\u00bb\u00bb custom_margin_phone=\u00bb||0px||false|false\u00bb custom_margin_last_edited=\u00bbon|phone\u00bb custom_padding_tablet=\u00bb\u00bb custom_padding_phone=\u00bb||0px|10px|false|false\u00bb custom_padding_last_edited=\u00bbon|phone\u00bb text_font_size_tablet=\u00bb22px\u00bb text_font_size_phone=\u00bb16px\u00bb text_font_size_last_edited=\u00bbon|phone\u00bb text_line_height_tablet=\u00bb1.33em\u00bb text_line_height_phone=\u00bb1.2em\u00bb text_line_height_last_edited=\u00bbon|phone\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<p>ASCERTAIN (Affordability and Sustainability improvements through new pricing, Cost- Effectiveness and ReimbursemenT models to Appraise INnovative health technologies) aborda la necesidad de pacientes, m\u00e9dicos, pagadores, reguladores y fabricantes de mejorar la asequibilidad y accesibilidad a las tecnolog\u00edas sanitarias innovadoras (incluidos los productos farmac\u00e9uticos) en Europa.<\/p>\n<p>[\/et_pb_text][et_pb_button button_url=\u00bbhttps:\/\/www.access2meds.eu\/es\/impacto\/\u00bb button_text=\u00bb\u00a1Descubre c\u00f3mo puedes beneficiarte!\u00bb button_alignment=\u00bbright\u00bb module_class=\u00bbbubble-button\u00bb _builder_version=\u00bb4.20.2&#8243; _module_preset=\u00bbdefault\u00bb custom_button=\u00bbon\u00bb button_text_size=\u00bb24px\u00bb button_text_color=\u00bb#FFFFFF\u00bb button_bg_color=\u00bbRGBA(255,255,255,0)\u00bb button_border_width=\u00bb0px\u00bb button_font=\u00bb||||||||\u00bb button_icon=\u00bb&#x39;||divi||400&#8243; button_on_hover=\u00bboff\u00bb button_text_size_tablet=\u00bb24px\u00bb button_text_size_phone=\u00bb16px\u00bb button_text_size_last_edited=\u00bbon|phone\u00bb custom_css_main_element=\u00bbfont-weight:500;\u00bb custom_css_after=\u00bbborder-radius: 50%;background: #e85d6b;||    width: 30px;||    height: 30px;||    text-align: center; top:10px;||    line-height: 30px !important;\u00bb global_colors_info=\u00bb{}\u00bb custom_css_after_last_edited=\u00bbon|phone\u00bb custom_css_after_phone=\u00bbborder-radius: 50%;background: #e85d6b;||    width: 20px;||    height: 20px;||    text-align: center; top:8px;||    line-height: 20px !important;\u00bb custom_css_after_tablet=\u00bbborder-radius: 50%;background: #e85d6b;||    width: 30px;||    height: 30px;||    text-align: center; top:10px;||    line-height: 30px !important;\u00bb][\/et_pb_button][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=\u00bb1&#8243; admin_label=\u00bbfaq\u00bb module_id=\u00bbascertain-faq\u00bb _builder_version=\u00bb4.20.2&#8243; _module_preset=\u00bbdefault\u00bb overflow-x=\u00bbhidden\u00bb custom_padding=\u00bb0px||0px||false|false\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_row _builder_version=\u00bb4.20.0&#8243; _module_preset=\u00bbdefault\u00bb custom_padding=\u00bb0px|30px||30px|false|true\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4&#8243; _builder_version=\u00bb4.20.0&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.20.2&#8243; _module_preset=\u00bbdefault\u00bb text_font=\u00bb|600|||||||\u00bb text_font_size=\u00bb36px\u00bb header_font=\u00bb|600|||||||\u00bb header_text_align=\u00bbleft\u00bb header_text_color=\u00bb#FFFFFF\u00bb header_font_size=\u00bb36px\u00bb header_line_height=\u00bb75px\u00bb background_color=\u00bb#e85d6b\u00bb background_image=\u00bbhttps:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/fastforward.svg\u00bb background_size=\u00bbcustom\u00bb background_image_width=\u00bb31px\u00bb background_image_height=\u00bb30px\u00bb background_position=\u00bbcenter_right\u00bb background_horizontal_offset=\u00bb27px\u00bb width=\u00bb160px\u00bb height=\u00bb75px\u00bb height_tablet=\u00bb75px\u00bb height_phone=\u00bb50px\u00bb height_last_edited=\u00bbon|phone\u00bb custom_padding=\u00bb|86px|||false|false\u00bb link_option_url=\u00bbhttps:\/\/www.access2meds.eu\/faq\/\u00bb header_font_size_tablet=\u00bb36px\u00bb header_font_size_phone=\u00bb24px\u00bb header_line_height_tablet=\u00bb75px\u00bb header_line_height_phone=\u00bb50px\u00bb header_line_height_last_edited=\u00bbon|phone\u00bb custom_css_main_element=\u00bboverflow:visible;\u00bb custom_css_after=\u00bbcontent:%22%22; display:block; width:2000px; height:100%; background:#e85d6b; position:absolute; top:0;right:160px;\u00bb border_radii=\u00bboff||9999px|9999px|\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<h1>FAQ<\/h1>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.20.0&#8243; _module_preset=\u00bbdefault\u00bb background_color=\u00bb#fbedec\u00bb positioning=\u00bbabsolute\u00bb position_origin_a=\u00bbtop_center\u00bb vertical_offset=\u00bb408px\u00bb max_width=\u00bb100%\u00bb height=\u00bb675px\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4&#8243; _builder_version=\u00bb4.20.0&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=\u00bb1_2,1_2&#8243; _builder_version=\u00bb4.20.0&#8243; _module_preset=\u00bbdefault\u00bb custom_padding=\u00bb|30px|60px|30px|false|true\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb1_2&#8243; _builder_version=\u00bb4.20.0&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_blurb title=\u00bb\u00bfQu\u00e9 es ASCERTAIN?\u00bb image=\u00bbhttps:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/iStock-542576580_sturti-1024&#215;683.jpg\u00bb image_icon_width=\u00bb100%\u00bb _builder_version=\u00bb4.20.2&#8243; _module_preset=\u00bb4d864e31-c790-4706-8bfe-634bfca688dd\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<p>ASCERTAIN es un proyecto destinado a ayudar a las personas a tener mejor acceso a nuevas tecnolog\u00edas sanitarias, como medicamentos, dispositivos m\u00e9dicos y pruebas\/an\u00e1lisis. El proyecto est\u00e1 creando una herramienta que puedan utilizar los responsables de la toma de decisiones para comprender el coste y el valor de estas nuevas tecnolog\u00edas sanitarias. <\/p>\n<p>[\/et_pb_blurb][et_pb_blurb title=\u00bb\u00bfQu\u00e9 es la herramienta de apoyo a las pol\u00edticas ASCERTAIN?\u00bb image=\u00bbhttps:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/iStock-1349268982-1024&#215;683.jpg\u00bb image_icon_width=\u00bb100%\u00bb _builder_version=\u00bb4.20.2&#8243; _module_preset=\u00bb4d864e31-c790-4706-8bfe-634bfca688dd\u00bb background_color=\u00bb#393C84&#8243; custom_margin_tablet=\u00bb||0px||false|false\u00bb custom_margin_phone=\u00bb||0px||false|false\u00bb custom_margin_last_edited=\u00bbon|tablet\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<p>La herramienta ser\u00e1 accesible a todo el mundo en Internet y tendr\u00e1 informaci\u00f3n sobre el coste y el valor de estas nuevas tecnolog\u00edas sanitarias. Tambi\u00e9n tendr\u00e1 en cuenta el impacto sobre el medio ambiente. El proyecto colaborar\u00e1 con pacientes, industria, responsables pol\u00edticos y pagadores para garantizar que la herramienta sea de buena calidad y \u00fatil.  <\/p>\n<p>[\/et_pb_blurb][\/et_pb_column][et_pb_column type=\u00bb1_2&#8243; _builder_version=\u00bb4.20.0&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb custom_css_main_element_last_edited=\u00bbon|tablet\u00bb custom_css_main_element_tablet=\u00bbmargin-bottom:0 !important;\u00bb custom_css_main_element_phone=\u00bbmargin-bottom:0 !important;\u00bb][et_pb_blurb title=\u00bb\u00bfPor qu\u00e9 es un reto la asequibilidad de las tecnolog\u00edas sanitarias innovadoras?\u00bb image=\u00bbhttps:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/iStock-1440000552-1024&#215;683.jpg\u00bb _builder_version=\u00bb4.20.2&#8243; _module_preset=\u00bb4d864e31-c790-4706-8bfe-634bfca688dd\u00bb background_color=\u00bb#E85D6B\u00bb custom_margin=\u00bb60px||30px||false|false\u00bb custom_margin_tablet=\u00bb0px||30px||false|false\u00bb custom_margin_phone=\u00bb0px||30px||false|false\u00bb custom_margin_last_edited=\u00bbon|tablet\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<p>Para muchos pa\u00edses de la Uni\u00f3n Europea es un reto financiar nuevas tecnolog\u00edas sanitarias, porque a menudo son costosas y no todo el mundo tiene el mismo acceso a ellas. Esta herramienta ayudar\u00e1 a los responsables de la toma de decisiones a comprender cu\u00e1nto debe costar una tecnolog\u00eda, el valor a\u00f1adido que aporta a los pacientes y su posible impacto en el presupuesto sanitario. <\/p>\n<p>[\/et_pb_blurb][et_pb_blurb title=\u00bb\u00bfCu\u00e1les son los objetivos de ASCERTAIN?\u00bb image=\u00bbhttps:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/Foto_1132274611_iStock_PeopleImages-1024&#215;653.jpg\u00bb _builder_version=\u00bb4.20.2&#8243; _module_preset=\u00bb4d864e31-c790-4706-8bfe-634bfca688dd\u00bb background_color=\u00bb#86B8BD\u00bb custom_margin=\u00bb||||false|false\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<p>El objetivo de ASCERTAIN es facilitar a los ciudadanos la comprensi\u00f3n del coste y el valor de las nuevas tecnolog\u00edas sanitarias. La herramienta estar\u00e1 abierta a todo el mundo y podr\u00e1 adaptarse a las necesidades de los distintos pa\u00edses. Contar\u00e1 con informaci\u00f3n sobre el coste y el valor de estas tecnolog\u00edas y fomentar\u00e1 una producci\u00f3n m\u00e1s \u201cverde\u201d.  <\/p>\n<p>[\/et_pb_blurb][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=\u00bb1&#8243; disabled_on=\u00bbon|on|off\u00bb module_id=\u00bbidioma\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb background_color=\u00bbrgba(134,184,189,0.3)\u00bb background_enable_image=\u00bboff\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_row _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4&#8243; _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<h3>\u00bfPREFIERES LEER ESTA P\u00c1GINA EN OTRO IDIOMA?<\/h3>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=\u00bb1_4,1_4,1_4,1_4&#8243; _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb1_4&#8243; _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_image src=\u00bbhttps:\/\/www.access2meds.eu\/wp-content\/uploads\/2025\/05\/Sprechblase_Englisch-1.png\u00bb title_text=\u00bbSprechblase_Espa\u00f1ol\u00bb url=\u00bbhttps:\/\/www.access2meds.eu\/es\/\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_image][et_pb_image src=\u00bbhttps:\/\/www.access2meds.eu\/wp-content\/uploads\/2025\/06\/Sprechblase_Nederlands.png\u00bb title_text=\u00bbSprechblase_Nederlands\u00bb url=\u00bbhttps:\/\/www.access2meds.eu\/nl\/\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_image][\/et_pb_column][et_pb_column type=\u00bb1_4&#8243; _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_image src=\u00bbhttps:\/\/www.access2meds.eu\/wp-content\/uploads\/2025\/05\/Sprechblase_Deutsch.png\u00bb title_text=\u00bbSprechblase_Deutsch\u00bb url=\u00bbhttps:\/\/www.access2meds.eu\/de\/\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_image][et_pb_image src=\u00bbhttps:\/\/www.access2meds.eu\/wp-content\/uploads\/2025\/05\/Sprechblase_France.png\u00bb title_text=\u00bbSprechblase_Francia\u00bb url=\u00bbhttps:\/\/www.access2meds.eu\/fr\/\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_image][\/et_pb_column][et_pb_column type=\u00bb1_4&#8243; _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_image src=\u00bbhttps:\/\/www.access2meds.eu\/wp-content\/uploads\/2025\/05\/Sprechblase_Romana.png\u00bb title_text=\u00bbSprechblase_Romana\u00bb url=\u00bbhttps:\/\/www.access2meds.eu\/ro\/\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_image][et_pb_image src=\u00bbhttps:\/\/www.access2meds.eu\/wp-content\/uploads\/2025\/06\/Sprechblase_Espanol.png\u00bb title_text=\u00bbSprechblase_Espanol\u00bb url=\u00bbhttps:\/\/www.access2meds.eu\/es\/\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_image][\/et_pb_column][et_pb_column type=\u00bb1_4&#8243; _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_image src=\u00bbhttps:\/\/www.access2meds.eu\/wp-content\/uploads\/2025\/05\/Sprechblase_Norsk.png\u00bb title_text=\u00bbSprechblase_Norsk\u00bb url=\u00bbhttps:\/\/www.access2meds.eu\/no\/\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_image][et_pb_image src=\u00bbhttps:\/\/www.access2meds.eu\/wp-content\/uploads\/2025\/05\/Sprechblase_Hrvatski.png\u00bb title_text=\u00bbSprechblase_Hrvatski\u00bb url=\u00bbhttps:\/\/www.access2meds.eu\/hr\/\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_image][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=\u00bb1&#8243; admin_label=\u00bbevents\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_row _builder_version=\u00bb4.20.0&#8243; _module_preset=\u00bbdefault\u00bb custom_padding=\u00bb14px|30px|4px|30px|false|true\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4&#8243; _builder_version=\u00bb4.20.0&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.25.1&#8243; _module_preset=\u00bbdefault\u00bb text_font=\u00bb|600|||||||\u00bb text_font_size=\u00bb36px\u00bb header_font=\u00bb|600||on|||||\u00bb header_text_align=\u00bbleft\u00bb header_text_color=\u00bb#FFFFFF\u00bb header_font_size=\u00bb36px\u00bb header_line_height=\u00bb75px\u00bb background_color=\u00bb#393C84&#8243; background_image=\u00bbhttps:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/fastforward.svg\u00bb background_size=\u00bbcustom\u00bb background_image_width=\u00bb31px\u00bb background_image_height=\u00bb30px\u00bb background_position=\u00bbcenter_right\u00bb background_horizontal_offset=\u00bb27px\u00bb width=\u00bb222px\u00bb height=\u00bb75px\u00bb height_tablet=\u00bb75px\u00bb height_phone=\u00bb50px\u00bb height_last_edited=\u00bbon|phone\u00bb custom_padding=\u00bb|60px|||false|false\u00bb link_option_url=\u00bbhttps:\/\/www.access2meds.eu\/news-events\/#ascertain-events\u00bb header_font_size_tablet=\u00bb36px\u00bb header_font_size_phone=\u00bb24px\u00bb header_line_height_tablet=\u00bb75px\u00bb header_line_height_phone=\u00bb50px\u00bb header_line_height_last_edited=\u00bbon|phone\u00bb custom_css_main_element=\u00bboverflow:visible;\u00bb custom_css_after=\u00bbcontent:%22%22; display:block; width:2000px; height:100%; background:#393c84; position:absolute; top:0;right:222px;\u00bb border_radii=\u00bboff||9999px|9999px|\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<h1>Events<\/h1>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.20.0&#8243; _module_preset=\u00bbdefault\u00bb max_width=\u00bb1170px\u00bb custom_padding=\u00bb0px|0px||0px|false|true\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4&#8243; _builder_version=\u00bb4.20.0&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_code _builder_version=\u00bb4.20.0&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb]<div class=\"em-view-container\" id=\"em-view-772684660\" data-view=\"list\">\r\n\t<div class=\"em-list em-events-list\" id=\"em-events-list-772684660\" data-view-id=\"772684660\">\r\n\t<div class=\"em-event em-item\" style=\"--default-border:#_CATEGORYCOLOR;\">\r\n\t<div class=\"em-meta-dates\">\r\n\t\t\t<div class=\"date\">\r\n\t\t\t\t<span class=\"day\">21 <br>-<br>21<\/span>\r\n\t\t\t\t<span class=\"month\">Oct<\/span>\r\n\t\t\t<\/div>\r\n\t<\/div>\r\n\t\r\n\t<div class=\"em-item-info\">\r\n\t\t<div class=\"em-content\">\r\n\t\t\t\r\n\t\t\r\n\t\t<h3 class=\"em-item-title\"><a href=\"https:\/\/www.access2meds.eu\/es\/events\/ascertain-final-conference\/\">ASCERTAIN Final Conference<\/a><\/h3>\r\n\r\n\t\t<div class=\"em-item-desc\">\r\n\t\t\t<p>Join us in Brussels for our final ASCERTAIN conference.<\/p>\n\r\n\t\t\t\r\n\t\t<\/div>\r\n\t\t<\/div>\r\n\t\t<div class=\"em-item-actions input\">\r\n\t\t\t<a class=\"em-item-read-more button\" href=\"https:\/\/www.access2meds.eu\/es\/events\/ascertain-final-conference\/\"><\/a>\r\n\t\t\t\r\n\t\t<\/div>\r\n\t<\/div>\r\n<\/div>\t<\/div>\r\n<\/div>[\/et_pb_code][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=\u00bb1&#8243; admin_label=\u00bbpartnerlogos\u00bb module_id=\u00bbascertain-news\u00bb _builder_version=\u00bb4.20.2&#8243; _module_preset=\u00bbdefault\u00bb background_color=\u00bb#FFFFFF\u00bb custom_padding=\u00bb0px||0px||true|false\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_row _builder_version=\u00bb4.20.0&#8243; _module_preset=\u00bbdefault\u00bb positioning=\u00bbabsolute\u00bb position_origin_a=\u00bbtop_center\u00bb custom_padding=\u00bb0px|30px|0px|30px|true|true\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4&#8243; _builder_version=\u00bb4.20.0&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.24.2&#8243; _module_preset=\u00bbdefault\u00bb text_font=\u00bb|600|||||||\u00bb text_font_size=\u00bb36px\u00bb header_font=\u00bb|600|||||||\u00bb header_text_align=\u00bbleft\u00bb header_text_color=\u00bb#FFFFFF\u00bb header_font_size=\u00bb36px\u00bb header_line_height=\u00bb75px\u00bb background_color=\u00bb#86B8BD\u00bb background_image=\u00bbhttps:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/fastforward.svg\u00bb background_size=\u00bbcustom\u00bb background_image_width=\u00bb31px\u00bb background_image_height=\u00bb30px\u00bb background_position=\u00bbcenter_right\u00bb background_horizontal_offset=\u00bb27px\u00bb width=\u00bb340px\u00bb width_tablet=\u00bb340px\u00bb width_phone=\u00bb250px\u00bb width_last_edited=\u00bbon|phone\u00bb height=\u00bb75px\u00bb height_tablet=\u00bb75px\u00bb height_phone=\u00bb50px\u00bb height_last_edited=\u00bbon|phone\u00bb custom_padding=\u00bb|86px|||false|false\u00bb link_option_url=\u00bbhttps:\/\/www.access2meds.eu\/es\/consorcio\/\u00bb header_font_size_tablet=\u00bb36px\u00bb header_font_size_phone=\u00bb24px\u00bb header_line_height_tablet=\u00bb75px\u00bb header_line_height_phone=\u00bb50px\u00bb header_line_height_last_edited=\u00bbon|phone\u00bb custom_css_main_element=\u00bboverflow:visible;\u00bb custom_css_after=\u00bbcontent:%22%22; display:block; width:2000px; height:100%; background:#048ea3; position:absolute; top:0;right:100%;\u00bb border_radii=\u00bboff||9999px|9999px|\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<h1>V\u00cdDEO<\/h1>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=\u00bb1&#8243; admin_label=\u00bbnews\u00bb module_id=\u00bbascertain-news\u00bb _builder_version=\u00bb4.20.2&#8243; _module_preset=\u00bbdefault\u00bb background_color=\u00bb#E85D6B\u00bb custom_padding=\u00bb0px||0px||true|false\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_row _builder_version=\u00bb4.20.2&#8243; _module_preset=\u00bbdefault\u00bb positioning=\u00bbabsolute\u00bb position_origin_a=\u00bbtop_center\u00bb z_index=\u00bb100&#8243; custom_padding=\u00bb0px|30px|0px|30px|true|true\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4&#8243; _builder_version=\u00bb4.20.2&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.20.2&#8243; _module_preset=\u00bbdefault\u00bb text_font=\u00bb|600|||||||\u00bb text_font_size=\u00bb36px\u00bb header_font=\u00bb|600||on|||||\u00bb header_text_align=\u00bbleft\u00bb header_text_color=\u00bb#FFFFFF\u00bb header_font_size=\u00bb36px\u00bb header_line_height=\u00bb75px\u00bb background_color=\u00bb#048EA3&#8243; background_image=\u00bbhttps:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/fastforward.svg\u00bb background_size=\u00bbcustom\u00bb background_image_width=\u00bb31px\u00bb background_image_height=\u00bb30px\u00bb background_position=\u00bbcenter_right\u00bb background_horizontal_offset=\u00bb27px\u00bb width=\u00bb190px\u00bb height=\u00bb75px\u00bb height_tablet=\u00bb75px\u00bb height_phone=\u00bb50px\u00bb height_last_edited=\u00bbon|phone\u00bb custom_padding=\u00bb|60px|||false|false\u00bb link_option_url=\u00bbhttps:\/\/www.access2meds.eu\/news-events\/\u00bb header_font_size_tablet=\u00bb36px\u00bb header_font_size_phone=\u00bb24px\u00bb header_line_height_tablet=\u00bb75px\u00bb header_line_height_phone=\u00bb50px\u00bb header_line_height_last_edited=\u00bbon|phone\u00bb custom_css_main_element=\u00bboverflow:visible;\u00bb custom_css_after=\u00bbcontent:%22%22; display:block; width:2000px; height:100%; background:#048ea3; position:absolute; top:0;right:100%;\u00bb border_radii=\u00bboff||9999px|9999px|\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<h1>News<\/h1>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.20.0&#8243; _module_preset=\u00bbdefault\u00bb max_width=\u00bb100%\u00bb module_alignment=\u00bbcenter\u00bb custom_padding=\u00bb0px|0px|0px||true|false\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4&#8243; _builder_version=\u00bb4.20.0&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_dp_dmb_module_205 _builder_version=\u00bb4.20.0&#8243; _module_preset=\u00bbdefault\u00bb custom_padding=\u00bb|||30px|false|false\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_dp_dmb_module_205][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=\u00bb1&#8243; _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb background_enable_color=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_row _builder_version=\u00bb4.24.2&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4&#8243; _builder_version=\u00bb4.24.2&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb header_2_font=\u00bb|600||on|||||\u00bb max_width=\u00bb70%\u00bb module_alignment=\u00bbcenter\u00bb custom_margin=\u00bb||||false|false\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<h2>Mira nuestros v\u00eddeos para saber m\u00e1s sobre el proyecto.<\/h2>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=\u00bb1_3,1_3,1_3&#8243; _builder_version=\u00bb4.24.2&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb1_3&#8243; _builder_version=\u00bb4.24.2&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_video src=\u00bbhttps:\/\/www.youtube.com\/watch?v=JjYDG7BDNDE\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb max_width=\u00bb70%\u00bb module_alignment=\u00bbcenter\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_video][et_pb_text _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb max_width=\u00bb70%\u00bb module_alignment=\u00bbcenter\u00bb custom_margin=\u00bb||||false|false\u00bb custom_padding=\u00bb10px||10px||false|false\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<p>Descubre el \u201cmaking of\u201d de la serie de seis cap\u00edtulos \u201c3 Cosas Sobre\u201d. En seis v\u00eddeos pretendemos hacer m\u00e1s accesibles cuestiones complejas, fomentando una comprensi\u00f3n m\u00e1s profunda de los retos y oportunidades en temas relacionados con ASCERTAIN. <\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=\u00bb1_3&#8243; _builder_version=\u00bb4.24.2&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_video src=\u00bbhttps:\/\/www.youtube.com\/watch?v=6ZtwscRvEls\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb max_width=\u00bb70%\u00bb module_alignment=\u00bbcenter\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_video][et_pb_text _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb max_width=\u00bb70%\u00bb module_alignment=\u00bbcenter\u00bb custom_margin=\u00bb||||false|false\u00bb custom_padding=\u00bb10px||10px||false|false\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<p>\u201c3 cosas sobre el valor de nuevos medicamentos contra el c\u00e1ncer\u201d &#8211; \u00a1El sexto v\u00eddeo de nuestra serie! Este v\u00eddeo explora c\u00f3mo las distintas partes interesadas definen el valor de los nuevos medicamentos contra el c\u00e1ncer. <\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=\u00bb1_3&#8243; _builder_version=\u00bb4.24.2&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_video src=\u00bbhttps:\/\/youtu.be\/xMF2ddO9abM\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb max_width=\u00bb70%\u00bb module_alignment=\u00bbcenter\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_video][et_pb_text _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb max_width=\u00bb70%\u00bb module_alignment=\u00bbcenter\u00bb custom_margin=\u00bb||||false|false\u00bb custom_padding=\u00bb10px||10px||false|false\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<p>\u201c3 cosas sobre coste-efectividad\u201d &#8211; \u00a1El quinto v\u00eddeo de nuestra serie! Este v\u00eddeo explora el an\u00e1lisis de coste-efectividad, un m\u00e9todo clave para evaluar si los tratamientos proporcionan un buen valor.  <\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=\u00bb1_3,1_3,1_3&#8243; _builder_version=\u00bb4.24.2&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb1_3&#8243; _builder_version=\u00bb4.24.2&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_video src=\u00bbhttps:\/\/youtu.be\/e36OtJA90Qg\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb max_width=\u00bb70%\u00bb module_alignment=\u00bbcenter\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_video][et_pb_text _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb max_width=\u00bb70%\u00bb module_alignment=\u00bbcenter\u00bb custom_margin=\u00bb||||false|false\u00bb custom_padding=\u00bb10px||10px||false|false\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<p><span>\u201c3 cosas sobre reembolso\u00bb es el cuarto v\u00eddeo de nuestra serie. En este v\u00eddeo, exploramos las complejidades del reembolso de medicamentos, un factor clave para garantizar el acceso de los pacientes a nuevos medicamentos. <\/span><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=\u00bb1_3&#8243; _builder_version=\u00bb4.24.2&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_video src=\u00bbhttps:\/\/www.youtube.com\/watch?v=6ZtwscRvEls\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb max_width=\u00bb70%\u00bb module_alignment=\u00bbcenter\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_video][et_pb_text _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb max_width=\u00bb70%\u00bb module_alignment=\u00bbcenter\u00bb custom_margin=\u00bb||||false|false\u00bb custom_padding=\u00bb10px||10px||false|false\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<p>\u201c3 cosas sobre el precio de los nuevos medicamentos\u201d &#8211; \u00a1El tercer v\u00eddeo de nuestra serie! En este v\u00eddeo exploramos los factores que influyen en el precio de medicamentos, un tema crucial en la asequibilidad de la asistencia sanitaria.  <\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=\u00bb1_3&#8243; _builder_version=\u00bb4.24.2&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_video src=\u00bbhttps:\/\/www.youtube.com\/watch?v=OlmiWOpy6IA&#038;t=2s\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb max_width=\u00bb70%\u00bb module_alignment=\u00bbcenter\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_video][et_pb_text _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb max_width=\u00bb70%\u00bb module_alignment=\u00bbcenter\u00bb custom_margin=\u00bb||||false|false\u00bb custom_padding=\u00bb10px||10px||false|false\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<p>\u201c3 cosas sobre precios diferenciados\u201d &#8211; \u00a1El segundo v\u00eddeo de nuestra serie! En este v\u00eddeo, desglosamos el concepto de precios diferenciados, una estrategia utilizada para fijar precios de medicamentos diferentes seg\u00fan los pa\u00edses y los grupos de pacientes. <\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=\u00bb1_3,1_3,1_3&#8243; _builder_version=\u00bb4.24.2&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb1_3&#8243; _builder_version=\u00bb4.24.2&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_video src=\u00bbhttps:\/\/youtu.be\/8NhuaohK_Qg\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb max_width=\u00bb70%\u00bb module_alignment=\u00bbcenter\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_video][et_pb_text _builder_version=\u00bb4.24.2&#8243; _module_preset=\u00bbdefault\u00bb max_width=\u00bb70%\u00bb module_alignment=\u00bbcenter\u00bb custom_margin=\u00bb||||false|false\u00bb custom_padding=\u00bb10px||10px||false|false\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<p> \u201c3 cosas sobre acceso al mercado\u201d &#8211; \u00a1El primer v\u00eddeo de nuestra serie! En este v\u00eddeo, nos sumergimos en el concepto crucial del acceso al mercado, un proceso vital para poner nuevos medicamentos y tratamientos a disposici\u00f3n de los pacientes. <\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=\u00bb1_3&#8243; _builder_version=\u00bb4.24.2&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_video src=\u00bbhttps:\/\/www.youtube.com\/watch?v=fvjJ4-2nOxk\u00bb _builder_version=\u00bb4.24.2&#8243; _module_preset=\u00bbdefault\u00bb max_width=\u00bb70%\u00bb module_alignment=\u00bbcenter\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_video][et_pb_text _builder_version=\u00bb4.24.2&#8243; _module_preset=\u00bbdefault\u00bb max_width=\u00bb70%\u00bb module_alignment=\u00bbcenter\u00bb custom_margin=\u00bb||||false|false\u00bb custom_padding=\u00bb10px||10px||false|false\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<p><span>Descubre c\u00f3mo ASCERTAIN aborda las desigualdades en el acceso a las tecnolog\u00edas sanitarias con nuestro \u00faltimo v\u00eddeo animado. Inf\u00f3rmate sobre la misi\u00f3n del proyecto para mejorar la asequibilidad y la sostenibilidad, al tiempo que se promueve la innovaci\u00f3n y se tiene en cuenta el impacto medioambiental. <\/span><\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=\u00bb1_3&#8243; _builder_version=\u00bb4.24.2&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_video src=\u00bbhttps:\/\/youtu.be\/sbPnTmX8Uxs\u00bb _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb max_width=\u00bb70%\u00bb module_alignment=\u00bbcenter\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_video][et_pb_text _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb max_width=\u00bb70%\u00bb module_alignment=\u00bbcenter\u00bb custom_margin=\u00bb||||false|false\u00bb custom_padding=\u00bb10px||10px||false|false\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<p><span>Nos complace compartir nuestro v\u00eddeo sobre el lanzamiento del proyecto ASCERTAIN en R\u00f3terdam. Los miembros de nuestro consorcio se reunieron para dar el pistoletazo de salida a este proyecto de iniciativa financiado por HORIZON. <\/span><\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=\u00bb1&#8243; module_id=\u00bbcontacto\u00bb _builder_version=\u00bb4.20.2&#8243; _module_preset=\u00bbdefault\u00bb background_color=\u00bb#86B8BD\u00bb custom_margin=\u00bb||||false|false\u00bb custom_padding=\u00bb16px||75px||false|false\u00bb box_shadow_style=\u00bbpreset7&#8243; box_shadow_horizontal=\u00bb0px\u00bb box_shadow_vertical=\u00bb-274px\u00bb box_shadow_color=\u00bb#FFFFFF\u00bb global_module=\u00bb910&#8243; saved_tabs=\u00bball\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_row _builder_version=\u00bb4.20.2&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4&#8243; _builder_version=\u00bb4.20.2&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.20.2&#8243; _module_preset=\u00bbdefault\u00bb header_font=\u00bbPoppins semibold|||on|||||\u00bb header_font_size=\u00bb36px\u00bb custom_margin=\u00bb14px||23px||false|false\u00bb custom_margin_tablet=\u00bb\u00bb custom_margin_phone=\u00bb||30px||false|false\u00bb custom_margin_last_edited=\u00bbon|phone\u00bb header_font_size_phone=\u00bb24px\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<h1>Contacto<\/h1>\n<p>[\/et_pb_text][et_pb_text _builder_version=\u00bb4.20.2&#8243; _module_preset=\u00bbdefault\u00bb text_font=\u00bbPoppins regular||||||||\u00bb text_text_color=\u00bb#393C84&#8243; text_font_size=\u00bb24px\u00bb text_line_height=\u00bb1.33em\u00bb module_alignment=\u00bbright\u00bb custom_margin=\u00bb||0px||false|false\u00bb text_font_size_tablet=\u00bb\u00bb text_font_size_phone=\u00bb18px\u00bb text_font_size_last_edited=\u00bbon|phone\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<p>Ponte en contacto con nosotros si tienes alguna pregunta o comentario. Nos pondremos en contacto contigo lo antes posible. <\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row column_structure=\u00bb1_3,1_3,1_3&#8243; use_custom_gutter=\u00bbon\u00bb module_class=\u00bbtablet-three-cols\u00bb _builder_version=\u00bb4.20.2&#8243; _module_preset=\u00bbdefault\u00bb max_width_tablet=\u00bb980px\u00bb max_width_phone=\u00bb500px\u00bb max_width_last_edited=\u00bbon|phone\u00bb custom_padding=\u00bb0px|30px|0px|30px|false|true\u00bb global_colors_info=\u00bb{}\u00bb custom_css_main_element_last_edited=\u00bbon|phone\u00bb custom_css_main_element_tablet=\u00bbdisplay:flex;\u00bb custom_css_main_element_phone=\u00bbdisplay:flex; flex-direction:column;\u00bb][et_pb_column type=\u00bb1_3&#8243; _builder_version=\u00bb4.20.2&#8243; _module_preset=\u00bbbe0fba28-f74a-4ba0-9a8d-9cd30aca805d\u00bb global_colors_info=\u00bb{}\u00bb custom_css_main_element_last_edited=\u00bbon|tablet\u00bb custom_css_main_element_tablet=\u00bbmargin-bottom:0;\u00bb custom_css_main_element_phone=\u00bbmargin-bottom:20px;\u00bb][et_pb_image src=\u00bbhttps:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/Carin_Uyl-de-Groot.png\u00bb title_text=\u00bbCarin_Uyl-de-Groot\u00bb _builder_version=\u00bb4.20.2&#8243; _module_preset=\u00bba348f9e0-d57b-4c22-b522-c52b784fe57f\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_image][et_pb_text _builder_version=\u00bb4.20.2&#8243; _module_preset=\u00bbdefault\u00bb text_text_color=\u00bb#FFFFFF\u00bb link_text_color=\u00bb#FFFFFF\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<p>Para preguntas relacionadas con la investigaci\u00f3n:<\/p>\n<p><strong>Carin Uyl-de Groot<\/strong><br \/>Coordinadora del proyecto<\/p>\n<p>Universidad Erasmus de Rotterdam<br \/><a href=\"mailto:uyl@eshpm.eur.nl\">uyl@eshpm.eur.nl<\/a><br \/>Tel\u00e9fono: +31 10 4081583<\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=\u00bb1_3&#8243; _builder_version=\u00bb4.20.2&#8243; _module_preset=\u00bbbe0fba28-f74a-4ba0-9a8d-9cd30aca805d\u00bb background_color=\u00bb#393C84&#8243; global_colors_info=\u00bb{}\u00bb custom_css_main_element_last_edited=\u00bbon|phone\u00bb custom_css_main_element_tablet=\u00bbmargin-bottom:0;\u00bb custom_css_main_element_phone=\u00bbmargin-bottom:20px;\u00bb][et_pb_image src=\u00bbhttps:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/Marcel-Langone-1.png\u00bb title_text=\u00bbMarcel-Langone\u00bb align=\u00bbcenter\u00bb _builder_version=\u00bb4.20.2&#8243; _module_preset=\u00bba348f9e0-d57b-4c22-b522-c52b784fe57f\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_image][et_pb_text _builder_version=\u00bb4.20.2&#8243; _module_preset=\u00bbdefault\u00bb text_text_color=\u00bb#FFFFFF\u00bb link_text_color=\u00bb#FFFFFF\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<p>Para preguntas generales sobre el proyecto:<\/p>\n<p><strong>Marcel Langone Marques<\/strong><br \/>Director del proyecto<\/p>\n<p>Universidad Erasmus de Rotterdam<br \/><a href=\"mailto:marcel.langonemarques@eur.nl\">marcel.langonemarques@eur.nl<\/a><br \/>Tel\u00e9fono: +31 10 4081583<\/p>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=\u00bb1_3&#8243; _builder_version=\u00bb4.20.2&#8243; _module_preset=\u00bbbe0fba28-f74a-4ba0-9a8d-9cd30aca805d\u00bb background_color=\u00bb#048EA3&#8243; global_colors_info=\u00bb{}\u00bb][et_pb_image src=\u00bbhttps:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/06\/My-project-1-7.png\u00bb title_text=\u00bbMi proyecto-1 (7)\u00bb _builder_version=\u00bb4.21.0&#8243; _module_preset=\u00bba348f9e0-d57b-4c22-b522-c52b784fe57f\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_image][et_pb_text _builder_version=\u00bb4.20.2&#8243; _module_preset=\u00bbdefault\u00bb text_text_color=\u00bb#FFFFFF\u00bb link_text_color=\u00bb#FFFFFF\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<p>Para comunicaciones:<\/p>\n<p><strong>Lena Jessen<\/strong><br \/>Gestora del proyecto<\/p>\n<p>OptiMedis<br \/><a href=\"mailto:l.jessen@optimedis.de\">l.jessen@optimedis.de<\/a><br \/>Tel\u00e9fono: +49 40 226211490<\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=\u00bb1&#8243; admin_label=\u00bbpartnerlogos\u00bb module_id=\u00bbascertain-news\u00bb _builder_version=\u00bb4.20.2&#8243; _module_preset=\u00bbdefault\u00bb background_color=\u00bb#FFFFFF\u00bb custom_padding=\u00bb0px||0px||true|false\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_row _builder_version=\u00bb4.20.0&#8243; _module_preset=\u00bbdefault\u00bb positioning=\u00bbabsolute\u00bb position_origin_a=\u00bbtop_center\u00bb custom_padding=\u00bb0px|30px|0px|30px|true|true\u00bb locked=\u00bboff\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4&#8243; _builder_version=\u00bb4.20.0&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_text _builder_version=\u00bb4.20.2&#8243; _module_preset=\u00bbdefault\u00bb text_font=\u00bb|600|||||||\u00bb text_font_size=\u00bb36px\u00bb header_font=\u00bb|600|||||||\u00bb header_text_align=\u00bbleft\u00bb header_text_color=\u00bb#FFFFFF\u00bb header_font_size=\u00bb36px\u00bb header_line_height=\u00bb75px\u00bb background_color=\u00bb#048EA3&#8243; background_image=\u00bbhttps:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/fastforward.svg\u00bb background_size=\u00bbcustom\u00bb background_image_width=\u00bb31px\u00bb background_image_height=\u00bb30px\u00bb background_position=\u00bbcenter_right\u00bb background_horizontal_offset=\u00bb27px\u00bb width=\u00bb340px\u00bb width_tablet=\u00bb340px\u00bb width_phone=\u00bb250px\u00bb width_last_edited=\u00bbon|phone\u00bb height=\u00bb75px\u00bb height_tablet=\u00bb75px\u00bb height_phone=\u00bb50px\u00bb height_last_edited=\u00bbon|phone\u00bb custom_padding=\u00bb|86px|||false|false\u00bb link_option_url=\u00bbhttps:\/\/www.access2meds.eu\/es\/consorcio\/\u00bb header_font_size_tablet=\u00bb36px\u00bb header_font_size_phone=\u00bb24px\u00bb header_line_height_tablet=\u00bb75px\u00bb header_line_height_phone=\u00bb50px\u00bb header_line_height_last_edited=\u00bbon|phone\u00bb custom_css_main_element=\u00bboverflow:visible;\u00bb custom_css_after=\u00bbcontent:%22%22; display:block; width:2000px; height:100%; background:#048ea3; position:absolute; top:0;right:100%;\u00bb border_radii=\u00bboff||9999px|9999px|\u00bb global_colors_info=\u00bb{}\u00bb]<\/p>\n<h1>Partners<\/h1>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][et_pb_row _builder_version=\u00bb4.20.2&#8243; _module_preset=\u00bbdefault\u00bb module_alignment=\u00bbcenter\u00bb custom_padding=\u00bb90px|30px|0px|30px|false|true\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_column type=\u00bb4_4&#8243; _builder_version=\u00bb4.20.0&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][et_pb_dp_oc_custom show_arrow=\u00bboff\u00bb show_control=\u00bboff\u00bb thumbnail_size=\u00bbmedium_large\u00bb number_thumb=\u00bb4&#8243; number_thumb_tablet=\u00bb4&#8243; number_thumb_phone=\u00bb2&#8243; number_thumb_last_edited=\u00bbon|phone\u00bb item_margin=\u00bb20&#8243; _builder_version=\u00bb4.27.4&#8243; _module_preset=\u00bbdefault\u00bb custom_padding=\u00bb30px||135px||false|false\u00bb hover_enabled=\u00bb0&#8243; global_colors_info=\u00bb{}\u00bb sticky_enabled=\u00bb0&#8243;][et_pb_dp_oc_custom_item upload_image=\u00bbhttps:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/Chino.io-logo-1.png\u00bb url=\u00bbhttps:\/\/www.access2meds.eu\/consortium\/team-members-chino-srl\/\u00bb admin_title=\u00bbCINO.IO\u00bb _builder_version=\u00bb4.20.2&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_dp_oc_custom_item][et_pb_dp_oc_custom_item upload_image=\u00bbhttps:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/EUR-endorsement_01_RGB_2400_colour.png\u00bb url=\u00bbhttps:\/\/www.access2meds.eu\/consortium\/team-members-erasmus-universiteit-rotterdam\/\u00bb admin_title=\u00bbEUR\u00bb _builder_version=\u00bb4.20.2&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_dp_oc_custom_item][et_pb_dp_oc_custom_item upload_image=\u00bbhttps:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/MPE-Logo-1.png\u00bb url=\u00bbhttps:\/\/www.access2meds.eu\/consortium\/team-members-myeloma-patients-europe-aisbl\/\u00bb admin_title=\u00bbMP\u00bb _builder_version=\u00bb4.20.2&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_dp_oc_custom_item][et_pb_dp_oc_custom_item upload_image=\u00bbhttps:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/Comenius_University_Bratislava-1.svg\u00bb url=\u00bbhttps:\/\/www.access2meds.eu\/consortium\/team-members-comenius-university-bratislava\/\u00bb admin_title=\u00bbCUB\u00bb _builder_version=\u00bb4.20.2&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_dp_oc_custom_item][et_pb_dp_oc_custom_item upload_image=\u00bbhttps:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/R.png\u00bb url=\u00bbhttps:\/\/www.access2meds.eu\/consortium\/team-members-universitetet-i-oslo\/\u00bb admin_title=\u00bbUiO\u00bb _builder_version=\u00bb4.20.2&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_dp_oc_custom_item][et_pb_dp_oc_custom_item upload_image=\u00bbhttps:\/\/www.access2meds.eu\/wp-content\/uploads\/2024\/06\/wortbildmarke-goeg-RGB.png\u00bb url=\u00bbhttps:\/\/www.access2meds.eu\/consortium\/team-members-gesundheit-osterreich-gmbh\/\u00bb admin_title=\u00bbG\u00d6\u00bb _builder_version=\u00bb4.25.2&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_dp_oc_custom_item][et_pb_dp_oc_custom_item upload_image=\u00bbhttps:\/\/www.access2meds.eu\/wp-content\/uploads\/2024\/08\/Logo-EHA-Black.png\u00bb url=\u00bbhttps:\/\/www.access2meds.eu\/consortium\/team-members-european-hematology-association\/\u00bb admin_title=\u00bbEHA\u00bb _builder_version=\u00bb4.27.0&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_dp_oc_custom_item][et_pb_dp_oc_custom_item upload_image=\u00bbhttps:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/AIM-LOGO_png24-1.png\u00bb url=\u00bbhttps:\/\/www.access2meds.eu\/consortium\/team-members-association-internationale-de-la-mutualite-aim\/\u00bb admin_title=\u00bbAIM\u00bb _builder_version=\u00bb4.20.2&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_dp_oc_custom_item][et_pb_dp_oc_custom_item upload_image=\u00bbhttps:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/OptiMedis_RGB.svg\u00bb url=\u00bbhttps:\/\/www.access2meds.eu\/consortium\/team-members-optimedis-ag\/\u00bb admin_title=\u00bboptimedis\u00bb _builder_version=\u00bb4.20.2&#8243; _module_preset=\u00bbdefault\u00bb global_colors_info=\u00bb{}\u00bb][\/et_pb_dp_oc_custom_item][\/et_pb_dp_oc_custom][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>ASCERTAIN responde a la necesidad de pacientes, m\u00e9dicos, pagadores, reguladores y fabricantes de mejorar la asequibilidad y accesibilidad de las tecnolog\u00edas sanitarias innovadoras (incluidos los productos farmac\u00e9uticos) en Europa.<\/p>\n","protected":false},"author":1,"featured_media":3978,"parent":0,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"class_list":["post-3976","page","type-page","status-publish","has-post-thumbnail","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v23.8 (Yoast SEO v27.4) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>ASCERTAIN - MEJORAR EL ACCESO A LAS TECNOLOG\u00cdAS SANITARIAS INNOVADORAS<\/title>\n<meta name=\"description\" content=\"ASCERTAIN responde a la necesidad de pacientes, m\u00e9dicos, pagadores, reguladores y fabricantes de mejorar la asequibilidad y accesibilidad de las tecnolog\u00edas sanitarias innovadoras (incluidos los productos farmac\u00e9uticos) en Europa.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.access2meds.eu\/es\/pagina-de-inicio\/\" \/>\n<meta property=\"og:locale\" content=\"es_ES\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"DETERMINAR - MEJORAR EL ACCESO A LAS TECNOLOG\u00cdAS SANITARIAS INNOVADORAS\" \/>\n<meta property=\"og:description\" content=\"ASCERTAIN responde a la necesidad de pacientes, m\u00e9dicos, pagadores, reguladores y fabricantes de mejorar la asequibilidad y accesibilidad de las tecnolog\u00edas sanitarias innovadoras (incluidos los productos farmac\u00e9uticos) en Europa.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.access2meds.eu\/es\/pagina-de-inicio\/\" \/>\n<meta property=\"og:site_name\" content=\"ASCERTAIN\" \/>\n<meta property=\"article:modified_time\" content=\"2025-06-24T08:24:56+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/04\/Social_ASCERTAIN.png\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:title\" content=\"DETERMINAR - MEJORAR EL ACCESO A LAS TECNOLOG\u00cdAS SANITARIAS INNOVADORAS\" \/>\n<meta name=\"twitter:description\" content=\"ASCERTAIN responde a la necesidad de pacientes, m\u00e9dicos, pagadores, reguladores y fabricantes de mejorar la asequibilidad y accesibilidad de las tecnolog\u00edas sanitarias innovadoras (incluidos los productos farmac\u00e9uticos) en Europa.\" \/>\n<meta name=\"twitter:image\" content=\"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/04\/Social_ASCERTAIN.png\" \/>\n<meta name=\"twitter:site\" content=\"@ASCERTAIN_EU\" \/>\n<meta name=\"twitter:label1\" content=\"Tiempo de lectura\" \/>\n\t<meta name=\"twitter:data1\" content=\"26 minutos\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/es\\\/pagina-de-inicio\\\/\",\"url\":\"https:\\\/\\\/www.access2meds.eu\\\/es\\\/pagina-de-inicio\\\/\",\"name\":\"ASCERTAIN - MEJORAR EL ACCESO A LAS TECNOLOG\u00cdAS SANITARIAS INNOVADORAS\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/es\\\/pagina-de-inicio\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/es\\\/pagina-de-inicio\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.access2meds.eu\\\/wp-content\\\/uploads\\\/2023\\\/03\\\/iStock-1217229190_Nastasic.jpg\",\"datePublished\":\"2023-02-27T14:19:01+00:00\",\"dateModified\":\"2025-06-24T08:24:56+00:00\",\"description\":\"ASCERTAIN responde a la necesidad de pacientes, m\u00e9dicos, pagadores, reguladores y fabricantes de mejorar la asequibilidad y accesibilidad de las tecnolog\u00edas sanitarias innovadoras (incluidos los productos farmac\u00e9uticos) en Europa.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/es\\\/pagina-de-inicio\\\/#breadcrumb\"},\"inLanguage\":\"es\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.access2meds.eu\\\/es\\\/pagina-de-inicio\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/es\\\/pagina-de-inicio\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.access2meds.eu\\\/wp-content\\\/uploads\\\/2023\\\/03\\\/iStock-1217229190_Nastasic.jpg\",\"contentUrl\":\"https:\\\/\\\/www.access2meds.eu\\\/wp-content\\\/uploads\\\/2023\\\/03\\\/iStock-1217229190_Nastasic.jpg\",\"width\":1900,\"height\":1267},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/es\\\/pagina-de-inicio\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/www.access2meds.eu\\\/es\\\/pagina-de-inicio\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"P\u00e1gina de inicio\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#website\",\"url\":\"https:\\\/\\\/www.access2meds.eu\\\/\",\"name\":\"ASCERTAIN\",\"description\":\"IMPROVING ACCESS TO INNOVATIVE HEALTH TECHNOLOGIES\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.access2meds.eu\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"es\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#organization\",\"name\":\"ASCERTAIN\",\"url\":\"https:\\\/\\\/www.access2meds.eu\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"es\",\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.access2meds.eu\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/ASCERTAIN-logo.svg\",\"contentUrl\":\"https:\\\/\\\/www.access2meds.eu\\\/wp-content\\\/uploads\\\/2023\\\/02\\\/ASCERTAIN-logo.svg\",\"width\":1,\"height\":1,\"caption\":\"ASCERTAIN\"},\"image\":{\"@id\":\"https:\\\/\\\/www.access2meds.eu\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/x.com\\\/ASCERTAIN_EU\",\"https:\\\/\\\/www.linkedin.com\\\/company\\\/ascertain-eu\\\/\",\"https:\\\/\\\/www.youtube.com\\\/@ascertainproject\"]}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"ASCERTAIN - MEJORAR EL ACCESO A LAS TECNOLOG\u00cdAS SANITARIAS INNOVADORAS","description":"ASCERTAIN responde a la necesidad de pacientes, m\u00e9dicos, pagadores, reguladores y fabricantes de mejorar la asequibilidad y accesibilidad de las tecnolog\u00edas sanitarias innovadoras (incluidos los productos farmac\u00e9uticos) en Europa.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.access2meds.eu\/es\/pagina-de-inicio\/","og_locale":"es_ES","og_type":"article","og_title":"DETERMINAR - MEJORAR EL ACCESO A LAS TECNOLOG\u00cdAS SANITARIAS INNOVADORAS","og_description":"ASCERTAIN responde a la necesidad de pacientes, m\u00e9dicos, pagadores, reguladores y fabricantes de mejorar la asequibilidad y accesibilidad de las tecnolog\u00edas sanitarias innovadoras (incluidos los productos farmac\u00e9uticos) en Europa.","og_url":"https:\/\/www.access2meds.eu\/es\/pagina-de-inicio\/","og_site_name":"ASCERTAIN","article_modified_time":"2025-06-24T08:24:56+00:00","og_image":[{"url":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/04\/Social_ASCERTAIN.png","type":"","width":"","height":""}],"twitter_card":"summary_large_image","twitter_title":"DETERMINAR - MEJORAR EL ACCESO A LAS TECNOLOG\u00cdAS SANITARIAS INNOVADORAS","twitter_description":"ASCERTAIN responde a la necesidad de pacientes, m\u00e9dicos, pagadores, reguladores y fabricantes de mejorar la asequibilidad y accesibilidad de las tecnolog\u00edas sanitarias innovadoras (incluidos los productos farmac\u00e9uticos) en Europa.","twitter_image":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/04\/Social_ASCERTAIN.png","twitter_site":"@ASCERTAIN_EU","twitter_misc":{"Tiempo de lectura":"26 minutos"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/www.access2meds.eu\/es\/pagina-de-inicio\/","url":"https:\/\/www.access2meds.eu\/es\/pagina-de-inicio\/","name":"ASCERTAIN - MEJORAR EL ACCESO A LAS TECNOLOG\u00cdAS SANITARIAS INNOVADORAS","isPartOf":{"@id":"https:\/\/www.access2meds.eu\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.access2meds.eu\/es\/pagina-de-inicio\/#primaryimage"},"image":{"@id":"https:\/\/www.access2meds.eu\/es\/pagina-de-inicio\/#primaryimage"},"thumbnailUrl":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/iStock-1217229190_Nastasic.jpg","datePublished":"2023-02-27T14:19:01+00:00","dateModified":"2025-06-24T08:24:56+00:00","description":"ASCERTAIN responde a la necesidad de pacientes, m\u00e9dicos, pagadores, reguladores y fabricantes de mejorar la asequibilidad y accesibilidad de las tecnolog\u00edas sanitarias innovadoras (incluidos los productos farmac\u00e9uticos) en Europa.","breadcrumb":{"@id":"https:\/\/www.access2meds.eu\/es\/pagina-de-inicio\/#breadcrumb"},"inLanguage":"es","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.access2meds.eu\/es\/pagina-de-inicio\/"]}]},{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.access2meds.eu\/es\/pagina-de-inicio\/#primaryimage","url":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/iStock-1217229190_Nastasic.jpg","contentUrl":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/03\/iStock-1217229190_Nastasic.jpg","width":1900,"height":1267},{"@type":"BreadcrumbList","@id":"https:\/\/www.access2meds.eu\/es\/pagina-de-inicio\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/www.access2meds.eu\/es\/pagina-de-inicio\/"},{"@type":"ListItem","position":2,"name":"P\u00e1gina de inicio"}]},{"@type":"WebSite","@id":"https:\/\/www.access2meds.eu\/#website","url":"https:\/\/www.access2meds.eu\/","name":"ASCERTAIN","description":"IMPROVING ACCESS TO INNOVATIVE HEALTH TECHNOLOGIES","publisher":{"@id":"https:\/\/www.access2meds.eu\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.access2meds.eu\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"es"},{"@type":"Organization","@id":"https:\/\/www.access2meds.eu\/#organization","name":"ASCERTAIN","url":"https:\/\/www.access2meds.eu\/","logo":{"@type":"ImageObject","inLanguage":"es","@id":"https:\/\/www.access2meds.eu\/#\/schema\/logo\/image\/","url":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/02\/ASCERTAIN-logo.svg","contentUrl":"https:\/\/www.access2meds.eu\/wp-content\/uploads\/2023\/02\/ASCERTAIN-logo.svg","width":1,"height":1,"caption":"ASCERTAIN"},"image":{"@id":"https:\/\/www.access2meds.eu\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/x.com\/ASCERTAIN_EU","https:\/\/www.linkedin.com\/company\/ascertain-eu\/","https:\/\/www.youtube.com\/@ascertainproject"]}]}},"_links":{"self":[{"href":"https:\/\/www.access2meds.eu\/es\/wp-json\/wp\/v2\/pages\/3976","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.access2meds.eu\/es\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.access2meds.eu\/es\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.access2meds.eu\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.access2meds.eu\/es\/wp-json\/wp\/v2\/comments?post=3976"}],"version-history":[{"count":15,"href":"https:\/\/www.access2meds.eu\/es\/wp-json\/wp\/v2\/pages\/3976\/revisions"}],"predecessor-version":[{"id":4544,"href":"https:\/\/www.access2meds.eu\/es\/wp-json\/wp\/v2\/pages\/3976\/revisions\/4544"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.access2meds.eu\/es\/wp-json\/wp\/v2\/media\/3978"}],"wp:attachment":[{"href":"https:\/\/www.access2meds.eu\/es\/wp-json\/wp\/v2\/media?parent=3976"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}